nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—EPHA3—brain—endogenous depression	0.000967	0.00148	CbGeAlD
Crizotinib—ACVR1B—brain—endogenous depression	0.000967	0.00148	CbGeAlD
Crizotinib—TYK2—midbrain—endogenous depression	0.000964	0.00147	CbGeAlD
Crizotinib—IRAK1—adrenal gland—endogenous depression	0.000964	0.00147	CbGeAlD
Crizotinib—SRC—cardiovascular system—endogenous depression	0.000962	0.00147	CbGeAlD
Crizotinib—LIMK2—nervous system—endogenous depression	0.000962	0.00147	CbGeAlD
Crizotinib—BMP2K—endocrine gland—endogenous depression	0.000959	0.00146	CbGeAlD
Crizotinib—MAP3K3—pituitary gland—endogenous depression	0.000959	0.00146	CbGeAlD
Crizotinib—MAP4K5—pituitary gland—endogenous depression	0.000959	0.00146	CbGeAlD
Crizotinib—TEK—pituitary gland—endogenous depression	0.000959	0.00146	CbGeAlD
Crizotinib—IRAK1—midbrain—endogenous depression	0.000952	0.00145	CbGeAlD
Crizotinib—ACVR1—nervous system—endogenous depression	0.000952	0.00145	CbGeAlD
Crizotinib—MAP3K12—nervous system—endogenous depression	0.000952	0.00145	CbGeAlD
Crizotinib—TESK1—cerebellum—endogenous depression	0.000951	0.00145	CbGeAlD
Crizotinib—PTK2—thyroid gland—endogenous depression	0.000949	0.00145	CbGeAlD
Crizotinib—TBK1—thyroid gland—endogenous depression	0.000949	0.00145	CbGeAlD
Crizotinib—MERTK—central nervous system—endogenous depression	0.000947	0.00145	CbGeAlD
Crizotinib—CSF1R—adrenal cortex—endogenous depression	0.000946	0.00145	CbGeAlD
Crizotinib—RPS6KB1—adrenal gland—endogenous depression	0.000946	0.00144	CbGeAlD
Crizotinib—TYK2—thyroid gland—endogenous depression	0.000943	0.00144	CbGeAlD
Crizotinib—LCK—adrenal gland—endogenous depression	0.00094	0.00144	CbGeAlD
Crizotinib—FGR—adrenal gland—endogenous depression	0.00094	0.00144	CbGeAlD
Crizotinib—AXL—adrenal gland—endogenous depression	0.000936	0.00143	CbGeAlD
Crizotinib—RPS6KB1—midbrain—endogenous depression	0.000934	0.00143	CbGeAlD
Crizotinib—STK35—nervous system—endogenous depression	0.000932	0.00142	CbGeAlD
Crizotinib—IRAK1—thyroid gland—endogenous depression	0.00093	0.00142	CbGeAlD
Crizotinib—LIMK2—central nervous system—endogenous depression	0.000926	0.00141	CbGeAlD
Crizotinib—PTK2B—endocrine gland—endogenous depression	0.000926	0.00141	CbGeAlD
Crizotinib—MERTK—cerebellum—endogenous depression	0.000925	0.00141	CbGeAlD
Crizotinib—AXL—midbrain—endogenous depression	0.000925	0.00141	CbGeAlD
Crizotinib—JAK3—brain—endogenous depression	0.000922	0.00141	CbGeAlD
Crizotinib—EPHA6—brain—endogenous depression	0.000922	0.00141	CbGeAlD
Crizotinib—RIPK2—endocrine gland—endogenous depression	0.000918	0.0014	CbGeAlD
Crizotinib—DCLK1—brain—endogenous depression	0.000916	0.0014	CbGeAlD
Crizotinib—ACVR1—central nervous system—endogenous depression	0.000916	0.0014	CbGeAlD
Crizotinib—MAP3K12—central nervous system—endogenous depression	0.000916	0.0014	CbGeAlD
Crizotinib—EPHB6—pituitary gland—endogenous depression	0.000916	0.0014	CbGeAlD
Crizotinib—RPS6KB1—thyroid gland—endogenous depression	0.000913	0.00139	CbGeAlD
Crizotinib—PLK4—brain—endogenous depression	0.000911	0.00139	CbGeAlD
Crizotinib—LCK—thyroid gland—endogenous depression	0.000907	0.00139	CbGeAlD
Crizotinib—FGR—thyroid gland—endogenous depression	0.000907	0.00139	CbGeAlD
Crizotinib—STK4—brain—endogenous depression	0.000905	0.00138	CbGeAlD
Crizotinib—LIMK2—cerebellum—endogenous depression	0.000905	0.00138	CbGeAlD
Crizotinib—AXL—thyroid gland—endogenous depression	0.000904	0.00138	CbGeAlD
Crizotinib—NUAK2—cerebellum—endogenous depression	0.000902	0.00138	CbGeAlD
Crizotinib—SLK—adrenal gland—endogenous depression	0.000901	0.00138	CbGeAlD
Crizotinib—STK35—central nervous system—endogenous depression	0.000898	0.00137	CbGeAlD
Crizotinib—BMP2K—nervous system—endogenous depression	0.000897	0.00137	CbGeAlD
Crizotinib—FLT3—cerebellum—endogenous depression	0.000896	0.00137	CbGeAlD
Crizotinib—MAP3K12—cerebellum—endogenous depression	0.000896	0.00137	CbGeAlD
Crizotinib—ACVR1—cerebellum—endogenous depression	0.000896	0.00137	CbGeAlD
Crizotinib—EPHB4—adrenal gland—endogenous depression	0.000895	0.00137	CbGeAlD
Crizotinib—SLK—midbrain—endogenous depression	0.00089	0.00136	CbGeAlD
Crizotinib—JAK2—adrenal gland—endogenous depression	0.000889	0.00136	CbGeAlD
Crizotinib—EPHA4—endocrine gland—endogenous depression	0.000888	0.00136	CbGeAlD
Crizotinib—YES1—pituitary gland—endogenous depression	0.000885	0.00135	CbGeAlD
Crizotinib—EPHB4—midbrain—endogenous depression	0.000884	0.00135	CbGeAlD
Crizotinib—EPHA2—adrenal gland—endogenous depression	0.000878	0.00134	CbGeAlD
Crizotinib—STK35—cerebellum—endogenous depression	0.000877	0.00134	CbGeAlD
Crizotinib—TAOK3—pituitary gland—endogenous depression	0.000874	0.00133	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—endogenous depression	0.000871	0.00133	CbGeAlD
Crizotinib—SLK—thyroid gland—endogenous depression	0.00087	0.00133	CbGeAlD
Crizotinib—PTK2B—nervous system—endogenous depression	0.000867	0.00132	CbGeAlD
Crizotinib—BMP2K—central nervous system—endogenous depression	0.000864	0.00132	CbGeAlD
Crizotinib—CSF1R—cardiovascular system—endogenous depression	0.000864	0.00132	CbGeAlD
Crizotinib—EPHB4—thyroid gland—endogenous depression	0.000864	0.00132	CbGeAlD
Crizotinib—JAK2—thyroid gland—endogenous depression	0.000857	0.00131	CbGeAlD
Crizotinib—MAP4K5—adrenal gland—endogenous depression	0.000856	0.00131	CbGeAlD
Crizotinib—MAP3K3—adrenal gland—endogenous depression	0.000856	0.00131	CbGeAlD
Crizotinib—TEK—adrenal gland—endogenous depression	0.000856	0.00131	CbGeAlD
Crizotinib—TYRO3—brain—endogenous depression	0.000855	0.00131	CbGeAlD
Crizotinib—EPHA5—brain—endogenous depression	0.000855	0.00131	CbGeAlD
Crizotinib—ALK—brain—endogenous depression	0.000855	0.00131	CbGeAlD
Crizotinib—FER—brain—endogenous depression	0.000855	0.00131	CbGeAlD
Crizotinib—ABL2—cerebellum—endogenous depression	0.000855	0.00131	CbGeAlD
Crizotinib—PTK2—endocrine gland—endogenous depression	0.000853	0.0013	CbGeAlD
Crizotinib—TBK1—endocrine gland—endogenous depression	0.000853	0.0013	CbGeAlD
Crizotinib—LYN—brain—endogenous depression	0.000851	0.0013	CbGeAlD
Crizotinib—EPHA2—thyroid gland—endogenous depression	0.000847	0.00129	CbGeAlD
Crizotinib—TYK2—endocrine gland—endogenous depression	0.000847	0.00129	CbGeAlD
Crizotinib—TNK1—brain—endogenous depression	0.000847	0.00129	CbGeAlD
Crizotinib—MAP4K5—midbrain—endogenous depression	0.000846	0.00129	CbGeAlD
Crizotinib—MAP3K3—midbrain—endogenous depression	0.000846	0.00129	CbGeAlD
Crizotinib—TEK—midbrain—endogenous depression	0.000846	0.00129	CbGeAlD
Crizotinib—BMP2K—cerebellum—endogenous depression	0.000845	0.00129	CbGeAlD
Crizotinib—MAP4K1—brain—endogenous depression	0.000838	0.00128	CbGeAlD
Crizotinib—BMPR1B—brain—endogenous depression	0.000838	0.00128	CbGeAlD
Crizotinib—MAP3K19—brain—endogenous depression	0.000838	0.00128	CbGeAlD
Crizotinib—ABL1—brainstem—endogenous depression	0.000837	0.00128	CbGeAlD
Crizotinib—PTK2B—central nervous system—endogenous depression	0.000834	0.00127	CbGeAlD
Crizotinib—EPHA4—nervous system—endogenous depression	0.000831	0.00127	CbGeAlD
Crizotinib—MAP4K5—thyroid gland—endogenous depression	0.000826	0.00126	CbGeAlD
Crizotinib—TEK—thyroid gland—endogenous depression	0.000826	0.00126	CbGeAlD
Crizotinib—MAP3K3—thyroid gland—endogenous depression	0.000826	0.00126	CbGeAlD
Crizotinib—TNK2—brain—endogenous depression	0.000822	0.00126	CbGeAlD
Crizotinib—IGF1R—brain—endogenous depression	0.000822	0.00126	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—endogenous depression	0.00082	0.00125	CbGeAlD
Crizotinib—EPHB6—adrenal gland—endogenous depression	0.000818	0.00125	CbGeAlD
Crizotinib—PTK2B—cerebellum—endogenous depression	0.000816	0.00125	CbGeAlD
Crizotinib—FGR—endocrine gland—endogenous depression	0.000815	0.00125	CbGeAlD
Crizotinib—MAP3K2—nervous system—endogenous depression	0.000815	0.00124	CbGeAlD
Crizotinib—AXL—endocrine gland—endogenous depression	0.000812	0.00124	CbGeAlD
Crizotinib—MAP4K2—brain—endogenous depression	0.00081	0.00124	CbGeAlD
Crizotinib—RIPK2—cerebellum—endogenous depression	0.000809	0.00124	CbGeAlD
Crizotinib—EPHB6—midbrain—endogenous depression	0.000808	0.00123	CbGeAlD
Crizotinib—EPHA4—central nervous system—endogenous depression	0.0008	0.00122	CbGeAlD
Crizotinib—STK3—brain—endogenous depression	0.0008	0.00122	CbGeAlD
Crizotinib—TIE1—brain—endogenous depression	0.0008	0.00122	CbGeAlD
Crizotinib—TBK1—nervous system—endogenous depression	0.000798	0.00122	CbGeAlD
Crizotinib—PTK2—nervous system—endogenous depression	0.000798	0.00122	CbGeAlD
Crizotinib—TYK2—nervous system—endogenous depression	0.000793	0.00121	CbGeAlD
Crizotinib—YES1—adrenal gland—endogenous depression	0.000791	0.00121	CbGeAlD
Crizotinib—EPHB6—thyroid gland—endogenous depression	0.00079	0.00121	CbGeAlD
Crizotinib—MAP3K2—central nervous system—endogenous depression	0.000785	0.0012	CbGeAlD
Crizotinib—STK10—adrenal gland—endogenous depression	0.000784	0.0012	CbGeAlD
Crizotinib—EPHA4—cerebellum—endogenous depression	0.000782	0.00119	CbGeAlD
Crizotinib—YES1—midbrain—endogenous depression	0.000781	0.00119	CbGeAlD
Crizotinib—TAOK3—adrenal gland—endogenous depression	0.000781	0.00119	CbGeAlD
Crizotinib—AURKA—brain—endogenous depression	0.000779	0.00119	CbGeAlD
Crizotinib—EPHB4—endocrine gland—endogenous depression	0.000776	0.00119	CbGeAlD
Crizotinib—TESK1—brain—endogenous depression	0.000773	0.00118	CbGeAlD
Crizotinib—TAOK3—midbrain—endogenous depression	0.000771	0.00118	CbGeAlD
Crizotinib—JAK2—endocrine gland—endogenous depression	0.000771	0.00118	CbGeAlD
Crizotinib—PTK2—central nervous system—endogenous depression	0.000768	0.00117	CbGeAlD
Crizotinib—TBK1—central nervous system—endogenous depression	0.000768	0.00117	CbGeAlD
Crizotinib—RPS6KB1—nervous system—endogenous depression	0.000768	0.00117	CbGeAlD
Crizotinib—MAP3K2—cerebellum—endogenous depression	0.000767	0.00117	CbGeAlD
Crizotinib—CSF1R—pituitary gland—endogenous depression	0.000765	0.00117	CbGeAlD
Crizotinib—YES1—thyroid gland—endogenous depression	0.000763	0.00117	CbGeAlD
Crizotinib—TYK2—central nervous system—endogenous depression	0.000763	0.00117	CbGeAlD
Crizotinib—FGR—nervous system—endogenous depression	0.000763	0.00117	CbGeAlD
Crizotinib—EPHA2—endocrine gland—endogenous depression	0.000761	0.00116	CbGeAlD
Crizotinib—SRC—adrenal gland—endogenous depression	0.000761	0.00116	CbGeAlD
Crizotinib—AXL—nervous system—endogenous depression	0.00076	0.00116	CbGeAlD
Crizotinib—STK10—thyroid gland—endogenous depression	0.000756	0.00116	CbGeAlD
Crizotinib—TAOK3—thyroid gland—endogenous depression	0.000753	0.00115	CbGeAlD
Crizotinib—MERTK—brain—endogenous depression	0.000752	0.00115	CbGeAlD
Crizotinib—TBK1—cerebellum—endogenous depression	0.000751	0.00115	CbGeAlD
Crizotinib—PTK2—cerebellum—endogenous depression	0.000751	0.00115	CbGeAlD
Crizotinib—ABL1—adrenal cortex—endogenous depression	0.000748	0.00114	CbGeAlD
Crizotinib—TYK2—cerebellum—endogenous depression	0.000746	0.00114	CbGeAlD
Crizotinib—TEK—endocrine gland—endogenous depression	0.000743	0.00113	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—endogenous depression	0.000743	0.00113	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—endogenous depression	0.000743	0.00113	CbGeAlD
Crizotinib—RPS6KB1—central nervous system—endogenous depression	0.000739	0.00113	CbGeAlD
Crizotinib—IRAK1—cerebellum—endogenous depression	0.000736	0.00112	CbGeAlD
Crizotinib—LIMK2—brain—endogenous depression	0.000735	0.00112	CbGeAlD
Crizotinib—FGR—central nervous system—endogenous depression	0.000735	0.00112	CbGeAlD
Crizotinib—SRC—thyroid gland—endogenous depression	0.000734	0.00112	CbGeAlD
Crizotinib—NUAK2—brain—endogenous depression	0.000733	0.00112	CbGeAlD
Crizotinib—AXL—central nervous system—endogenous depression	0.000732	0.00112	CbGeAlD
Crizotinib—MAP3K12—brain—endogenous depression	0.000727	0.00111	CbGeAlD
Crizotinib—ACVR1—brain—endogenous depression	0.000727	0.00111	CbGeAlD
Crizotinib—RPS6KB1—cerebellum—endogenous depression	0.000722	0.0011	CbGeAlD
Crizotinib—JAK2—nervous system—endogenous depression	0.000721	0.0011	CbGeAlD
Crizotinib—AXL—cerebellum—endogenous depression	0.000715	0.00109	CbGeAlD
Crizotinib—STK35—brain—endogenous depression	0.000713	0.00109	CbGeAlD
Crizotinib—EPHA2—nervous system—endogenous depression	0.000713	0.00109	CbGeAlD
Crizotinib—TEK—nervous system—endogenous depression	0.000695	0.00106	CbGeAlD
Crizotinib—MAP3K3—nervous system—endogenous depression	0.000695	0.00106	CbGeAlD
Crizotinib—MAP4K5—nervous system—endogenous depression	0.000695	0.00106	CbGeAlD
Crizotinib—ABL2—brain—endogenous depression	0.000694	0.00106	CbGeAlD
Crizotinib—JAK2—central nervous system—endogenous depression	0.000694	0.00106	CbGeAlD
Crizotinib—SLK—cerebellum—endogenous depression	0.000688	0.00105	CbGeAlD
Crizotinib—EPHA2—central nervous system—endogenous depression	0.000686	0.00105	CbGeAlD
Crizotinib—BMP2K—brain—endogenous depression	0.000686	0.00105	CbGeAlD
Crizotinib—YES1—endocrine gland—endogenous depression	0.000686	0.00105	CbGeAlD
Crizotinib—EPHB4—cerebellum—endogenous depression	0.000684	0.00104	CbGeAlD
Crizotinib—CSF1R—adrenal gland—endogenous depression	0.000683	0.00104	CbGeAlD
Crizotinib—ABL1—cardiovascular system—endogenous depression	0.000683	0.00104	CbGeAlD
Crizotinib—STK10—endocrine gland—endogenous depression	0.00068	0.00104	CbGeAlD
Crizotinib—JAK2—cerebellum—endogenous depression	0.000679	0.00104	CbGeAlD
Crizotinib—TAOK3—endocrine gland—endogenous depression	0.000677	0.00103	CbGeAlD
Crizotinib—CSF1R—midbrain—endogenous depression	0.000674	0.00103	CbGeAlD
Crizotinib—MAP4K5—central nervous system—endogenous depression	0.000669	0.00102	CbGeAlD
Crizotinib—MAP3K3—central nervous system—endogenous depression	0.000669	0.00102	CbGeAlD
Crizotinib—TEK—central nervous system—endogenous depression	0.000669	0.00102	CbGeAlD
Crizotinib—EPHB6—nervous system—endogenous depression	0.000664	0.00101	CbGeAlD
Crizotinib—PTK2B—brain—endogenous depression	0.000663	0.00101	CbGeAlD
Crizotinib—SRC—endocrine gland—endogenous depression	0.00066	0.00101	CbGeAlD
Crizotinib—CSF1R—thyroid gland—endogenous depression	0.000659	0.00101	CbGeAlD
Crizotinib—RIPK2—brain—endogenous depression	0.000657	0.001	CbGeAlD
Crizotinib—MAP3K3—cerebellum—endogenous depression	0.000654	0.000999	CbGeAlD
Crizotinib—MAP4K5—cerebellum—endogenous depression	0.000654	0.000999	CbGeAlD
Crizotinib—TEK—cerebellum—endogenous depression	0.000654	0.000999	CbGeAlD
Crizotinib—YES1—nervous system—endogenous depression	0.000642	0.00098	CbGeAlD
Crizotinib—EPHB6—central nervous system—endogenous depression	0.00064	0.000977	CbGeAlD
Crizotinib—STK10—nervous system—endogenous depression	0.000636	0.000972	CbGeAlD
Crizotinib—EPHA4—brain—endogenous depression	0.000635	0.00097	CbGeAlD
Crizotinib—TAOK3—nervous system—endogenous depression	0.000634	0.000968	CbGeAlD
Crizotinib—EPHB6—cerebellum—endogenous depression	0.000625	0.000955	CbGeAlD
Crizotinib—MAP3K2—brain—endogenous depression	0.000623	0.000951	CbGeAlD
Crizotinib—YES1—central nervous system—endogenous depression	0.000618	0.000944	CbGeAlD
Crizotinib—SRC—nervous system—endogenous depression	0.000618	0.000943	CbGeAlD
Crizotinib—STK10—central nervous system—endogenous depression	0.000612	0.000935	CbGeAlD
Crizotinib—TAOK3—central nervous system—endogenous depression	0.00061	0.000932	CbGeAlD
Crizotinib—TBK1—brain—endogenous depression	0.00061	0.000932	CbGeAlD
Crizotinib—PTK2—brain—endogenous depression	0.00061	0.000932	CbGeAlD
Crizotinib—TYK2—brain—endogenous depression	0.000606	0.000925	CbGeAlD
Crizotinib—ABL1—pituitary gland—endogenous depression	0.000604	0.000923	CbGeAlD
Crizotinib—YES1—cerebellum—endogenous depression	0.000604	0.000923	CbGeAlD
Crizotinib—STK10—cerebellum—endogenous depression	0.000599	0.000914	CbGeAlD
Crizotinib—IRAK1—brain—endogenous depression	0.000598	0.000913	CbGeAlD
Crizotinib—TAOK3—cerebellum—endogenous depression	0.000596	0.000911	CbGeAlD
Crizotinib—SRC—central nervous system—endogenous depression	0.000595	0.000908	CbGeAlD
Crizotinib—CSF1R—endocrine gland—endogenous depression	0.000592	0.000905	CbGeAlD
Crizotinib—RPS6KB1—brain—endogenous depression	0.000587	0.000896	CbGeAlD
Crizotinib—FGR—brain—endogenous depression	0.000583	0.000891	CbGeAlD
Crizotinib—SRC—cerebellum—endogenous depression	0.000581	0.000888	CbGeAlD
Crizotinib—AXL—brain—endogenous depression	0.000581	0.000887	CbGeAlD
Crizotinib—SLK—brain—endogenous depression	0.000559	0.000854	CbGeAlD
Crizotinib—EPHB4—brain—endogenous depression	0.000555	0.000848	CbGeAlD
Crizotinib—CSF1R—nervous system—endogenous depression	0.000554	0.000847	CbGeAlD
Crizotinib—JAK2—brain—endogenous depression	0.000551	0.000842	CbGeAlD
Crizotinib—EPHA2—brain—endogenous depression	0.000545	0.000832	CbGeAlD
Crizotinib—ABL1—adrenal gland—endogenous depression	0.00054	0.000825	CbGeAlD
Crizotinib—CSF1R—central nervous system—endogenous depression	0.000534	0.000815	CbGeAlD
Crizotinib—ABL1—midbrain—endogenous depression	0.000533	0.000814	CbGeAlD
Crizotinib—TEK—brain—endogenous depression	0.000531	0.000811	CbGeAlD
Crizotinib—MAP4K5—brain—endogenous depression	0.000531	0.000811	CbGeAlD
Crizotinib—MAP3K3—brain—endogenous depression	0.000531	0.000811	CbGeAlD
Crizotinib—CSF1R—cerebellum—endogenous depression	0.000522	0.000797	CbGeAlD
Crizotinib—ABL1—thyroid gland—endogenous depression	0.000521	0.000796	CbGeAlD
Crizotinib—EPHB6—brain—endogenous depression	0.000508	0.000775	CbGeAlD
Crizotinib—YES1—brain—endogenous depression	0.000491	0.000749	CbGeAlD
Crizotinib—STK10—brain—endogenous depression	0.000486	0.000743	CbGeAlD
Crizotinib—TAOK3—brain—endogenous depression	0.000484	0.00074	CbGeAlD
Crizotinib—SRC—brain—endogenous depression	0.000472	0.000721	CbGeAlD
Crizotinib—ABL1—endocrine gland—endogenous depression	0.000468	0.000715	CbGeAlD
Crizotinib—ABL1—nervous system—endogenous depression	0.000438	0.000669	CbGeAlD
Crizotinib—CSF1R—brain—endogenous depression	0.000424	0.000647	CbGeAlD
Crizotinib—ABL1—central nervous system—endogenous depression	0.000422	0.000644	CbGeAlD
Crizotinib—ABL1—cerebellum—endogenous depression	0.000412	0.00063	CbGeAlD
Crizotinib—ABL1—brain—endogenous depression	0.000335	0.000512	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—endogenous depression	0.000274	0.000419	CbGeAlD
Crizotinib—ABCB1—forebrain—endogenous depression	0.000251	0.000383	CbGeAlD
Crizotinib—ABCB1—adrenal cortex—endogenous depression	0.000233	0.000355	CbGeAlD
Crizotinib—ABCB1—cardiovascular system—endogenous depression	0.000212	0.000324	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—endogenous depression	0.000206	0.000314	CbGeAlD
Crizotinib—CYP3A4—nervous system—endogenous depression	0.000193	0.000294	CbGeAlD
Crizotinib—ABCB1—pituitary gland—endogenous depression	0.000188	0.000287	CbGeAlD
Crizotinib—CYP3A4—central nervous system—endogenous depression	0.000185	0.000283	CbGeAlD
Crizotinib—ABCB1—adrenal gland—endogenous depression	0.000168	0.000256	CbGeAlD
Crizotinib—ABCB1—midbrain—endogenous depression	0.000166	0.000253	CbGeAlD
Crizotinib—ABCB1—thyroid gland—endogenous depression	0.000162	0.000247	CbGeAlD
Crizotinib—JAK3—Signaling by GPCR—HTR7—endogenous depression	0.000155	0.000449	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—HTR2A—endogenous depression	0.000154	0.000447	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CRH—endogenous depression	0.000152	0.000441	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—OXT—endogenous depression	0.000152	0.000441	CbGpPWpGaD
Crizotinib—PTK2—Immune System—WASF1—endogenous depression	0.000152	0.00044	CbGpPWpGaD
Crizotinib—YES1—Immune System—WASF1—endogenous depression	0.00015	0.000434	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HTR1A—endogenous depression	0.00015	0.000433	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—WASF2—endogenous depression	0.000148	0.00043	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—GATA3—endogenous depression	0.000148	0.00043	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—HTR2A—endogenous depression	0.000147	0.000425	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—CACNB2—endogenous depression	0.000147	0.000425	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—WASF2—endogenous depression	0.000147	0.000425	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HTR1A—endogenous depression	0.000146	0.000424	CbGpPWpGaD
Crizotinib—ABCB1—endocrine gland—endogenous depression	0.000146	0.000222	CbGeAlD
Crizotinib—SRC—Innate Immune System—WASF2—endogenous depression	0.000145	0.000421	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—POMC—endogenous depression	0.000145	0.00042	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HTR2C—endogenous depression	0.000144	0.000418	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—ADM—endogenous depression	0.000144	0.000418	CbGpPWpGaD
Crizotinib—TYK2—Immune System—WASF2—endogenous depression	0.000144	0.000417	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—WASF1—endogenous depression	0.000142	0.000412	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HTR2C—endogenous depression	0.000141	0.00041	CbGpPWpGaD
Crizotinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000141	0.000408	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—WASF1—endogenous depression	0.000141	0.000407	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—HTR7—endogenous depression	0.00014	0.000405	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—WASF1—endogenous depression	0.000139	0.000403	CbGpPWpGaD
Crizotinib—TYK2—Immune System—WASF1—endogenous depression	0.000138	0.0004	CbGpPWpGaD
Crizotinib—ABCB1—nervous system—endogenous depression	0.000136	0.000208	CbGeAlD
Crizotinib—SRC—Developmental Biology—CACNA1C—endogenous depression	0.000134	0.000388	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ADM—endogenous depression	0.000134	0.000388	CbGpPWpGaD
Crizotinib—ABCB1—central nervous system—endogenous depression	0.000131	0.0002	CbGeAlD
Crizotinib—RIPK2—Signaling Pathways—WASF2—endogenous depression	0.000131	0.000378	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—GATA3—endogenous depression	0.00013	0.000376	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—HTR2A—endogenous depression	0.000129	0.000375	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—HTR2A—endogenous depression	0.000129	0.000375	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—WASF2—endogenous depression	0.000129	0.000373	CbGpPWpGaD
Crizotinib—ABCB1—cerebellum—endogenous depression	0.000128	0.000196	CbGeAlD
Crizotinib—IGF1R—Signaling Pathways—HTR7—endogenous depression	0.000127	0.000367	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—WASF1—endogenous depression	0.000125	0.000363	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HTR7—endogenous depression	0.000124	0.000359	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—POMC—endogenous depression	0.000123	0.000358	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—WASF1—endogenous depression	0.000123	0.000358	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—WASF2—endogenous depression	0.000123	0.000357	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—POMC—endogenous depression	0.000123	0.000357	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—HTR2A—endogenous depression	0.000123	0.000355	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CRH—endogenous depression	0.000121	0.00035	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—OXT—endogenous depression	0.000121	0.00035	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—ADM—endogenous depression	0.00012	0.000348	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ADM—endogenous depression	0.000119	0.000346	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—WASF2—endogenous depression	0.000119	0.000346	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—HTR2A—endogenous depression	0.000119	0.000346	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—WASF1—endogenous depression	0.000118	0.000342	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ADM—endogenous depression	0.000118	0.000341	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—POMC—endogenous depression	0.000117	0.00034	CbGpPWpGaD
Crizotinib—LYN—Immune System—WASF2—endogenous depression	0.000117	0.000338	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR1A—endogenous depression	0.000116	0.000337	CbGpPWpGaD
Crizotinib—ABL1—Immune System—WASF2—endogenous depression	0.000116	0.000336	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—GATA3—endogenous depression	0.000115	0.000333	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—WASF1—endogenous depression	0.000115	0.000332	CbGpPWpGaD
Crizotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000113	0.000327	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ADM—endogenous depression	0.000113	0.000326	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—OXT—endogenous depression	0.000112	0.000325	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CRH—endogenous depression	0.000112	0.000325	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR2C—endogenous depression	0.000112	0.000325	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—HTR2A—endogenous depression	0.000112	0.000325	CbGpPWpGaD
Crizotinib—LYN—Immune System—WASF1—endogenous depression	0.000112	0.000324	CbGpPWpGaD
Crizotinib—ABL1—Immune System—WASF1—endogenous depression	0.000111	0.000322	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ADM—endogenous depression	0.000109	0.000317	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—ADM—endogenous depression	0.000109	0.000316	CbGpPWpGaD
Crizotinib—JAK2—Immune System—WASF2—endogenous depression	0.000109	0.000316	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—HTR2A—endogenous depression	0.000108	0.000314	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR1A—endogenous depression	0.000108	0.000313	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000108	0.000312	CbGpPWpGaD
Crizotinib—CYP3A5—Biological oxidations—POMC—endogenous depression	0.000105	0.000303	CbGpPWpGaD
Crizotinib—JAK2—Immune System—WASF1—endogenous depression	0.000105	0.000303	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR2C—endogenous depression	0.000104	0.000303	CbGpPWpGaD
Crizotinib—ABCB1—brain—endogenous depression	0.000104	0.000159	CbGeAlD
Crizotinib—ACVR1B—Signaling Pathways—POMC—endogenous depression	0.000103	0.000299	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—POMC—endogenous depression	0.000103	0.000299	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—WASF2—endogenous depression	0.000103	0.000297	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—WASF2—endogenous depression	0.000101	0.000293	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CRH—endogenous depression	0.000101	0.000292	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—OXT—endogenous depression	0.000101	0.000292	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—OXT—endogenous depression	0.0001	0.00029	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CRH—endogenous depression	0.0001	0.00029	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	9.94e-05	0.000288	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CRH—endogenous depression	9.87e-05	0.000286	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—OXT—endogenous depression	9.87e-05	0.000286	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR7—endogenous depression	9.83e-05	0.000285	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—WASF1—endogenous depression	9.83e-05	0.000285	CbGpPWpGaD
Crizotinib—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	9.8e-05	0.000284	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—HTR2A—endogenous depression	9.8e-05	0.000284	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—POMC—endogenous depression	9.79e-05	0.000284	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR1A—endogenous depression	9.7e-05	0.000281	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—WASF1—endogenous depression	9.69e-05	0.000281	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR1A—endogenous depression	9.64e-05	0.000279	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—NR3C1—endogenous depression	9.63e-05	0.000279	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—WASF2—endogenous depression	9.59e-05	0.000278	CbGpPWpGaD
Crizotinib—LCK—Immune System—WASF2—endogenous depression	9.56e-05	0.000277	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—POMC—endogenous depression	9.54e-05	0.000276	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR1A—endogenous depression	9.5e-05	0.000275	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—OXT—endogenous depression	9.44e-05	0.000274	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CRH—endogenous depression	9.44e-05	0.000274	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ADM—endogenous depression	9.38e-05	0.000272	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR2C—endogenous depression	9.37e-05	0.000271	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR2C—endogenous depression	9.31e-05	0.00027	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—WASF2—endogenous depression	9.31e-05	0.00027	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ADM—endogenous depression	9.25e-05	0.000268	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—WASF1—endogenous depression	9.19e-05	0.000266	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR2C—endogenous depression	9.17e-05	0.000266	CbGpPWpGaD
Crizotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	9.16e-05	0.000265	CbGpPWpGaD
Crizotinib—LCK—Immune System—WASF1—endogenous depression	9.16e-05	0.000265	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—OXT—endogenous depression	9.16e-05	0.000265	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CRH—endogenous depression	9.16e-05	0.000265	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—OXT—endogenous depression	9.15e-05	0.000265	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CRH—endogenous depression	9.15e-05	0.000265	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR7—endogenous depression	9.15e-05	0.000265	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR1A—endogenous depression	9.09e-05	0.000263	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—POMC—endogenous depression	8.95e-05	0.000259	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—WASF1—endogenous depression	8.92e-05	0.000259	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HTR2A—endogenous depression	8.86e-05	0.000257	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR1A—endogenous depression	8.82e-05	0.000255	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR1A—endogenous depression	8.81e-05	0.000255	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR2C—endogenous depression	8.78e-05	0.000254	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ADM—endogenous depression	8.77e-05	0.000254	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HTR2A—endogenous depression	8.67e-05	0.000251	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—POMC—endogenous depression	8.66e-05	0.000251	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ADM—endogenous depression	8.51e-05	0.000247	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR2C—endogenous depression	8.51e-05	0.000247	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR2C—endogenous depression	8.51e-05	0.000247	CbGpPWpGaD
Crizotinib—SRC—Immune System—WASF2—endogenous depression	8.46e-05	0.000245	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR7—endogenous depression	8.21e-05	0.000238	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR7—endogenous depression	8.15e-05	0.000236	CbGpPWpGaD
Crizotinib—SRC—Immune System—WASF1—endogenous depression	8.11e-05	0.000235	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR7—endogenous depression	8.04e-05	0.000233	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—OXT—endogenous depression	7.86e-05	0.000228	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CRH—endogenous depression	7.86e-05	0.000228	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—POMC—endogenous depression	7.83e-05	0.000227	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CRH—endogenous depression	7.75e-05	0.000224	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—OXT—endogenous depression	7.75e-05	0.000224	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR7—endogenous depression	7.69e-05	0.000223	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR1A—endogenous depression	7.56e-05	0.000219	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—WASF2—endogenous depression	7.54e-05	0.000218	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—COMT—endogenous depression	7.53e-05	0.000218	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—MAOA—endogenous depression	7.48e-05	0.000217	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR1A—endogenous depression	7.46e-05	0.000216	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR7—endogenous depression	7.46e-05	0.000216	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR7—endogenous depression	7.45e-05	0.000216	CbGpPWpGaD
Crizotinib—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	7.43e-05	0.000215	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—OXT—endogenous depression	7.35e-05	0.000213	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CRH—endogenous depression	7.35e-05	0.000213	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR2C—endogenous depression	7.3e-05	0.000212	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—WASF1—endogenous depression	7.23e-05	0.000209	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR2C—endogenous depression	7.2e-05	0.000209	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CRH—endogenous depression	7.13e-05	0.000207	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—OXT—endogenous depression	7.13e-05	0.000207	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—POMC—endogenous depression	7.08e-05	0.000205	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR1A—endogenous depression	7.07e-05	0.000205	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—WASF2—endogenous depression	7.05e-05	0.000204	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—POMC—endogenous depression	6.93e-05	0.000201	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ADM—endogenous depression	6.89e-05	0.0002	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—HTR2A—endogenous depression	6.89e-05	0.0002	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR1A—endogenous depression	6.87e-05	0.000199	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR2C—endogenous depression	6.83e-05	0.000198	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—WASF1—endogenous depression	6.76e-05	0.000196	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR2C—endogenous depression	6.63e-05	0.000192	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ADM—endogenous depression	6.45e-05	0.000187	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HTR2A—endogenous depression	6.41e-05	0.000186	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR7—endogenous depression	6.4e-05	0.000185	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR7—endogenous depression	6.31e-05	0.000183	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—WASF2—endogenous depression	6.18e-05	0.000179	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—TPH1—endogenous depression	6.03e-05	0.000175	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR7—endogenous depression	5.98e-05	0.000173	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—WASF1—endogenous depression	5.92e-05	0.000172	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR7—endogenous depression	5.81e-05	0.000168	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CRH—endogenous depression	5.78e-05	0.000167	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—OXT—endogenous depression	5.78e-05	0.000167	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—HTR2A—endogenous depression	5.75e-05	0.000167	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HTR2A—endogenous depression	5.71e-05	0.000165	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADM—endogenous depression	5.65e-05	0.000164	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HTR2A—endogenous depression	5.63e-05	0.000163	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR1A—endogenous depression	5.56e-05	0.000161	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—POMC—endogenous depression	5.5e-05	0.000159	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—WASF2—endogenous depression	5.47e-05	0.000158	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—OXT—endogenous depression	5.41e-05	0.000157	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CRH—endogenous depression	5.41e-05	0.000157	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HTR2A—endogenous depression	5.39e-05	0.000156	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2C—endogenous depression	5.37e-05	0.000156	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—WASF1—endogenous depression	5.24e-05	0.000152	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HTR2A—endogenous depression	5.22e-05	0.000151	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—HTR2A—endogenous depression	5.22e-05	0.000151	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR1A—endogenous depression	5.2e-05	0.000151	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—POMC—endogenous depression	5.12e-05	0.000148	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2C—endogenous depression	5.03e-05	0.000146	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADM—endogenous depression	5e-05	0.000145	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—POMC—endogenous depression	4.87e-05	0.000141	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CRH—endogenous depression	4.74e-05	0.000137	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—OXT—endogenous depression	4.74e-05	0.000137	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR7—endogenous depression	4.7e-05	0.000136	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—POMC—endogenous depression	4.59e-05	0.000133	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—TPH2—endogenous depression	4.57e-05	0.000132	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CACNB2—endogenous depression	4.57e-05	0.000132	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—POMC—endogenous depression	4.56e-05	0.000132	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR1A—endogenous depression	4.56e-05	0.000132	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TPH1—endogenous depression	4.55e-05	0.000132	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—DPYD—endogenous depression	4.5e-05	0.00013	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—POMC—endogenous depression	4.49e-05	0.00013	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HTR2A—endogenous depression	4.48e-05	0.00013	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HTR2A—endogenous depression	4.42e-05	0.000128	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2C—endogenous depression	4.4e-05	0.000128	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR7—endogenous depression	4.4e-05	0.000128	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—POMC—endogenous depression	4.3e-05	0.000125	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CRH—endogenous depression	4.19e-05	0.000121	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—OXT—endogenous depression	4.19e-05	0.000121	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HTR2A—endogenous depression	4.19e-05	0.000121	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CACNA1C—endogenous depression	4.18e-05	0.000121	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—POMC—endogenous depression	4.17e-05	0.000121	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—POMC—endogenous depression	4.17e-05	0.000121	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HTR2A—endogenous depression	4.07e-05	0.000118	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR1A—endogenous depression	4.04e-05	0.000117	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2C—endogenous depression	3.9e-05	0.000113	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR7—endogenous depression	3.86e-05	0.000112	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP2D6—endogenous depression	3.65e-05	0.000106	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—POMC—endogenous depression	3.58e-05	0.000104	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—POMC—endogenous depression	3.53e-05	0.000102	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TPH2—endogenous depression	3.45e-05	9.99e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CACNB2—endogenous depression	3.45e-05	9.99e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR7—endogenous depression	3.41e-05	9.89e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DPYD—endogenous depression	3.39e-05	9.83e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—POMC—endogenous depression	3.35e-05	9.7e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HTR2A—endogenous depression	3.3e-05	9.55e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—POMC—endogenous depression	3.25e-05	9.41e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CACNA1C—endogenous depression	3.16e-05	9.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HTR2A—endogenous depression	3.08e-05	8.93e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TPH1—endogenous depression	2.8e-05	8.12e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—COMT—endogenous depression	2.77e-05	8.02e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP2D6—endogenous depression	2.76e-05	7.99e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MAOA—endogenous depression	2.75e-05	7.97e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HTR2A—endogenous depression	2.7e-05	7.82e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—POMC—endogenous depression	2.63e-05	7.62e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—POMC—endogenous depression	2.46e-05	7.13e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HTR2A—endogenous depression	2.39e-05	6.93e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—POMC—endogenous depression	2.16e-05	6.25e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TPH2—endogenous depression	2.13e-05	6.16e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CACNB2—endogenous depression	2.13e-05	6.16e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DPYD—endogenous depression	2.09e-05	6.06e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—COMT—endogenous depression	2.09e-05	6.05e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MAOA—endogenous depression	2.08e-05	6.01e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.94e-05	5.63e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—endogenous depression	1.91e-05	5.53e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—endogenous depression	1.79e-05	5.19e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.7e-05	4.92e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—endogenous depression	1.35e-05	3.91e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—COMT—endogenous depression	1.29e-05	3.73e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOA—endogenous depression	1.28e-05	3.7e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—endogenous depression	8.32e-06	2.41e-05	CbGpPWpGaD
